News
Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today unveiled new real-world U.S. physician preference data for the SOFIA™ 88 ...
Company also announces new 500-patient SUMMIT RISE study at the Society of NeuroInterventional Surgery annual meetingSAN MATEO, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a ...
Company to Showcase Progress on Radical Catheter Portfolio and Best-in-Class Ribbon Technology Platform at Society of ...
12d
MedPage Today on MSNNerve-Illuminating Agent Shows Early Promise for Reducing Surgical MorbidityDespite advances in surgical techniques and technology, iatrogenic nerve injury remains a leading cause of morbidity ...
Elad Levy is an internationally renowned neurovascular surgeon, who has played a pioneering role in innovating neurosurgical techniques, which have improved the survival and quality of life for stroke ...
MicroVention, Inc., a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced its official rebranding to Terumo Neuro, effective immediately.
Q’Apel Medical, Inc. announced it has received FDA clearance for the Zebra neurovascular access system, which is indicated fo ...
MicroVention, Inc., a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced its official rebranding to Terumo Neuro, effective immediately ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results